SUMMARY -Th e purpose of this study was to create a fi brin-based human skin substitute in vitro with epidermal and dermal component and to assess its healing potential in deep partial and full thickness burns. Fibrin scaff olds were prepared from commercial fi brin glue kits. Human fi broblasts were cultured in fi brin gel. Human keratinocytes were seeded on the top of the gel. Viability of cells was determined fl uorimetrically. Scanning electron microscope and immunocytochemistry analysis of cultured cells were performed. After hydrosurgical preparation of deep burn necrotic tissue, wound bed was prepared for skin substitutes. Progress of healing was documented using visual estimation and photos. Scanning electron microscope images showed good cell attachment and colony spreading of keratinocytes and fi broblasts on fi brin scaff old. Immunofl uorescent staining of cell cultures on fi brin scaff old showed expression of vimentin, a marker of fi broblast cells, cytokeratin 19, a marker of epithelial stem cells, as well as involucrin, a marker of diff erentiated keratinocytes. Clinical results clearly showed that appearance of the skin did not diff er signifi cantly from the areas of transplanted skin using split-thickness skin graft techniques. In conclusion, using these fi brin-cultured autografts on massive full-thickness burn resulted in good healing.
Introduction
Th e treatment of burns becomes much more complicated when wounds are deep and extensive. When a burn has penetrated deeper into the dermis, skin regeneration relies only on stem cell reservoirs located in epithelial appendages such as hair follicles, sebaceous glands, and sweat glands [1] [2] [3] [4] . When these reservoirs are destroyed, epithelialization can only start from wound margins. For deep partial and full thickness burns, necrotic tissue excision and wound closure with epidermal and partial dermal substitution is mandatory. Th e existence of dermal components is necessary for skin repair. At the end of the infl ammation phase of the wound healing process, the fi rst wave of fi broblasts migrates from dermal margins to the wound bed attracted by local growth factors/cytokines. Th ey start to proliferate and form granulation tissue. Fibronectin, collagen, hyaluronan, and other components of granulation tissue create a moist environment which facilitates further cell migration. In the proliferative and remodeling phases of healing, the keratinocyte-fi broblast interplay becomes dominant. Re-epithelialization starts as soon as granulation tissue fi lls an open wound; epithelial cells move over the surface of this provisional matrix, creating a barrier between the wound and the environment 5 . Studies of keratinocyte and fi broblast cocultures show that keratinocytes stimulate fi broblasts to synthesize growth factors, which in turn stimulate keratinocyte proliferation in a double paracrine manner. Both types of cells contribute to the synthesis of macromolecules of basement membrane. Fibroblasts produce collagen type IV and VII, laminin 5, nidogen, and transforming growth factor beta (TGF-b), which in turn stimulates keratinocytes to synthesize collagen type IV and VII. Considering the importance of the keratinocyte-fi broblast interaction for the wound healing process, creating a complete skin equivalent with epidermal and dermal components has become a major focus of recent tissue engineering research 6, 7 . Th e choice of artifi cial extracellular matrix or scaffold is particularly important. It off ers skin stem cells an optimal environment for in vitro growth and differentiation. Scaff olds for skin engineering must meet three basic criteria: patient safety, clinical effi cacy, and convenience of use 8 . Th ey should also have good mechanical and physical properties, controlled degradation rate, low immunogenicity, etc. 9, 10 . Fibrin as a natural, biodegradable polypeptide is involved in the initial phase of wound healing. Th e fibrin network provides a temporary scaff old which directs the early migration of fi broblasts and vascular endothelial cells into the wound bed 11 . Fibrin gel is frequently used in medicine as a tissue fi xative. Over the last twenty years, it has been extensively studied in the tissue engineering fi eld as a cell scaff old and as a material for delivering growth factors and genes to promote wound healing. Fibrin hydrogels could be prepared from commercial fi brin glue or from the patient's own plasma. Th ey are used in tissue engineering of bone, skin, as well as cartilage, dental, cardiac and eye tissue 12, 13 . Th e utilization of fi brin gel in skin engineering started in 1988, with fi brin glue fi xation of cultivated keratinocytes to the wound bed 14 . In several studies, burned patients were successfully treated with keratinocytes in fi brin gel [15] [16] [17] . Fibrin has also been used as a scaff old for cultivating dermal cell components. Th e presence of dermal fi broblasts in fi brin gel stimulated keratinocyte migration, increased the secretion of vascular endothelial growth factor (VEGF), improved regeneration of mature epidermal structure after in vivo transplantation, and promoted migration of vascular endothelial cells [18] [19] [20] [21] [22] [23] . Th e aim of our study was in vitro creation of a fibrin-based substitute with epidermal and dermal components. We tested the viability of human keratinocytes and fi broblasts grown in this fi brin matrix. Th is substitute was consequently applied to the burn areas of patients with deep partial and full thickness burns.
Patients and Methods

Ethics
Human skin samples were used upon approval granted by the Ethics Committee of the Clinical Department of Traumatology and having obtained informed consents from the patients.
Cell isolation and culture
For clinical application, upon Ethics Committee approval, human skin samples of approximately 2 cm 2 were obtained from patient 1, a 14-year-old boy with electrocombustion and 65% of Total Body Surface Area (TBSA) burns caused by high voltage, and from patient 2, a 5-year-old patient with combustion, 95% TBSA burns caused by hot water. Burns were of depth degree IIb-III. Skin samples for cultivation were used from donor sites in non burned areas. In all other tests, skin cells from surgical surplus tissue were used. Cell isolation and culture were carried out under aseptic conditions in a clean room facility. Skin samples were washed in antibiotic-antimycotic solution (ABAM; Invitrogen, Carlsbad, California, USA) with amphotericin B (2 g/mL), penicillin (100 U/mL) and streptomycin (0.1 mg/mL) and placed overnight at 4 °C in a solution of 4.4 mg/mL Dispase (Invitrogen, Carlsbad, California, USA) in phosphate buff ered saline (PBS; Sigma Aldrich, St. Louis, Missouri, USA). Th e next day, the epidermis was peeled off from the dermis. Both skin parts were cut into small fragments. Dermal fragments were placed in Petri dish with fi broblast growth medium containing Dulbecco's Modified Eagle Medium (DMEM; Invitrogen, Carlsbad, California, USA), 10% of heat inactivated Australian Fetal Bovine Serum (FBS; Invitrogen Gibco, USA), ABAM (1%) and 1% L-glutamine (Invitrogen, Carlsbad, California, USA). Fibroblasts were cultured at 37 °C, 5% CO 2 until 80% confl uence. Afterwards, they were passaged. Fibroblasts from the second or third passage were used for all other experiments. Epidermal parts were incubated with 0.25% trypsin (Sigma Aldrich, St. Louis, Missouri, USA) at 37 °C for 30 minutes. Trypsin was neutralizated with keratinocyte growth medium containing 10% FBS, 2:1 DMEM: Ham's F-12 (Invitrogen, Carlsbad, California, USA), 2% Lglutamin, 1% ABAM, 5 μg/mL insulin (Sigma Aldrich, St. Louis, Missouri, USA), 0.18 mM adenine (Sigma Aldrich, St. Louis, Missouri, USA), 0.4 μg/mL hydrocortisone (Sigma Aldrich, St. Louis, Missouri, USA), 0.1 nM cholera toxin (Accurate Chemicals & Sicentifi c Corporation, New York, USA), 2 nM triiodothyronine (Sigma Aldrich, St. Louis, Missouri, USA) and 10 ng/mL epidermal growth factor (EGF) (Sigma Aldrich, St. Louis, Missouri, USA). Isolated cells were seeded at a 2:1 ratio on a lethally irradiated feeder layer of 3T3 cells. Culture medium was changed every third day. Cells were passaged at 80% of confl uence. Keratinocytes from the second passage were used in all other procedures.
Preparation of cultured epithelial autografts
Cultured epithelial autografts (CEA) were prepared for clinical application according to the Rheinwald and Green method (Fig. 1a ) 24 . Keratinocytes were cultured on a feeder layer of irradiated 3T3 cells at a 2:1 ratio in 75 cm 2 tissue culture fl asks until full confl uence. On the day of grafting, epithelial sheets were detached with Dispase (Invitrogen, Carlsbad, California, USA) from tissue culture fl asks and mounted on sterile silicon gauze (Mepitel, Mölnlycke Health Care AB, Gothenburg, Sweden). Sheets were washed and delivered to the operation room in serum free medium.
Preparation of skin equivalent on fi brin scaff old
Fibrin scaff olds were prepared aseptically from commercial 2 mL fi brin glue kits (Tisseel, Baxter AG, Vienna, Austria, EU) containing fi brinogen, aprotinin and thrombin components 17 . All components of the kit were kept in water bath at 37 °C prior to manipulation. Fibrinogen powder was dissolved in 1 mL aprotinin and equal volume of solubilization saline containing 1.1% NaCl and 1 mM CaCl 2 . Th rombin part was reconstituted with the same saline from 500 IU/ mL to 3 IU/mL and mixed, for clinical purpose, with human dermal fi broblasts, 20 000 cells/cm 2 (Fig. 1b) . Equal parts of thrombin and fi brinogen solution were added simultaneously with duploject application system into tissue culture vessels: (Ø=90 mm) Petri dishes or 75 cm 2 fl asks. In order to prevent strong gluing of the fi brin scaff old to the surface of the vessel, caused by negative charge of cell culture plastic for adherent cells, nonadherent variant of tissue plastic was used. Fibroblast growth medium was added after fi brin gel polymerization. Fibroblast cultures were kept in incubator at 37 °C, 5% CO 2 . When fi broblasts in fi brin gel reached 80% of confl uence, keratinocytes without feeder layer were seeded on the top of the gels at a concentration of 40 000 cells/cm 2 . Keratinocyte growth medium was supplemented with tranexamic acid (Cyklokapron, Pfizer, Karlsruhe, Germany) to prevent fibrinolysis of gel by growing cells. Medium was changed every third day. For clinical application, gels at 70%-90% of keratinocyte confl uence were delivered to the operation room in sterile Petri dishes with serum free medium without tranexamic acid (Fig. 1b) . For viability tests, scanning electron microscope (SEM) and immunocytochemistry analysis, fi broblasts and keratinocytes were cultured individually, as described below, on fi brin scaff old.
Viability of cells cultured on fi brin scaff old
Normal human fi broblasts from 9 donors were seeded at a concentration of 100 000 cells/well on fibrin gels (as described previously) and in 96-well tissue culture plastic plates for adherent cultures. Cells were cultured for 4 days in fi broblast growth medium. Normal human keratinocytes from 9 donors were seeded at a concentration of 15 000 cells/well with irradiated 3T3 feeder layer (1:1 ratio in 96 well-plate on fi brin gel and on tissue culture plastic for adherent cultures). Cells were cultured for 10 days in keratinocyte growth medium. Twenty μL of CellTiter-Blue (Promega, Madison, WI, USA) reagent was added to 100 μL cell culture medium in each well according to the manufacturer's instructions. After 4-h incubation at 37 °C and 5% CO 2 , metabolically active cells reduced indicator dye resazurin into resorufi n, a highly fl uorescent product. Nonviable cells rapidly lost their metabolic capacity, did not reduce the indicator dye, and fl uorescent signal was not detected. Th e measured fl uorescence was proportional to the number of viable cells. All tests were performed in triplicate. Fluorescent signal was measured by fl uorometer (Fluoroskan II, Labsystems, USA) using a set of fi lters (544Ex/590Em).
Immunofl uorescence
Human keratinocytes with irradiated feeder layer of 3T3 cells (at a 1:1 ratio) and human fi broblasts were seeded at a concentration of 100 000 cells/well on fibrin gels in tissue culture grade glass chamber slides (Becton Dickinson Co., New Jersey, USA). Fibroblast or keratinocyte growth medium was changed every third day. Indirect immunocytochemistry was performed at 70% of cell culture confl uence. All antibodies were diluted in 1% bovine serum albumin (BSA) solution in PBS (Sigma Aldrich, St. Louis, Missouri, USA). Cells were fi xed for 10 minutes in 4% paraformaldehyde and permeabilized in 0.1% Triton X-100 (Sigma Aldrich, St. Louis, Missouri, USA) for 5 minutes. Samples were incubated with primary antibodies for 1 hour at room temperature. For fi broblast staining, primary goat antibody (whole serum) against human vimentin (Sigma Aldrich, St. Louis, Missouri, USA) was used at 1:20 dilution. For keratinocyte staining, monoclonal mouse antibody against human cytokeratine (CK) 19 (clone RCK108, Dako Denmark A/S, Agilent technologies, Santa Clara, USA) was diluted at 1:100. Mouse immunoglobulin (Ig) IgG1 antibody against human involucrin (clone SY5, Sigma Aldrich, St. Louis, Missouri, USA) was prepared at 1:50 dilution. Immunoreactivity of primary antibodies was visualized with secondary antibodies: rabbit anti-goat IgG fl uorescein isothiocyanate (FITC) antibody (Sigma Aldrich, St. Louis, Missouri, USA) at 1:400 dilution or rabbit anti-mouse IgG Alexa Flour 488 (Invitrogen, Carlsbad, California, USA) at 1:1000 dilution. Antibodies were incubated for 30 minutes in dark place at room temperature and counterstained with Propidium Iodide (Sigma Aldrich, St. Louis, Missouri, USA) 20 μg/mL for 5 minutes. Finally, the cells were treated with an antifade reagent (Prolong Antifade kit, Invitrogen, Carlsbad, California, USA) and observed under confocal microscope (TCS SP2 AOBS, Leica, Wetzlar, Germany).
Scanning electron microscope observation of cell cultures
Human fi broblasts or keratinocytes were seeded on the top of fi brin gels in 24-well culture plate, as described previously. Cells were grown until 80% of confl uence and analyzed with SEM (ESEM Philips XL30, Amsterdam, Netherlands).
Clinical application
Appropriate covering of burned parts of the body is vital for favorable results. Good preparation of wound bed is mandatory. In this study, the hydrosurgical VERSAJET system was used. Th is approach enables the surgeon to precisely select, excise and evacuate nonviable tissue, bacteria and contaminants from burned wound using a tissue-preserving technique. After hydrosurgical preparation of deep burn necrotic tissue, wound bed was prepared for Split-Th ickness Skin Grafts (STSG), CEA or skin equivalents (Fig. 2) . STSG, as valuable transplants of limited quantity in extensive burns, were put on the degree III wound areas with irregular surfaces. CEA were put on the degree IIb-III wound areas with even surfaces and distant margins (the patients' back and legs) and then fi xed to the surface with surgical staples. Skin equivalents were put on the areas that did not heal after the CEA application (the shoulder and the thigh).
Bacteriological status of the graft bed was monitored at regular intervals. Th e grafted areas were then covered with surgical non-adherent dressing. Signs of possible bleeding or infection were monitored daily. Dressings were changed twice a week. Progress of the healing was documented using visual estimation (visual estimation of scar height, pliability, surface area, texture, pigmentation, and vascularity) and photos.
Statistical analysis
Statistical analysis for viability studies was performed using the Statistica 9 (StatSoft Inc., 2010) software. Intensity of resorufi n fl uorescence was used as a value proportional to the number of viable cells. One-way ANOVA and Tukey post-hoc tests were used. Statistical signifi cance was set at P<0.05.
Results
Cultures were regularly examined using inverted phase-contrast microscope (MBL 3100, A. Krüss Optronic, Germany). In epithelial cultures on feeder layer, keratinocytes had a characteristic polygonal morphology. At lower stage of confl uence (Fig. 3a) , the supporting feeder layer of sub lethally irradiated mouse 3T3 cells and melanocytes with their dendritic morphology were still visible. Feeder cells, unable to divide, were metabolically active long enough to support growth and proliferation of keratinocytes. As kerati-
Fig. 2. Grafting of prepared wound bed with cultured epithelial autografts in patient 1 (A) and patient 2 (B), and with skin equivalents on fi brin scaff old in patient 1 (C, D).
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nocyte colonies spread across the surface of tissue culture vessel, 3T3 cells died. Dead feeder cells were removed from the fl ask during regular medium change. Fully confl uent keratinocyte cultures formed multilayered epithelial sheet ready for harvesting (Fig. 3b) . Cultures of dermal fi broblasts showed bipolar spindle morphology (Fig. 4a) . Cells cultured on fi brin gel were less visible when compared to those cultured on plastics ( Fig. 3c and 4b) . SEM images showed good cell attachment and colony spreading of keratinocytes and fi broblasts on fi brin scaff old (Fig. 5) .
In CellTiter-Blue test, only metabolically active, viable cells reduced the indicator dye, resazurin into fl uorescent resorufi n. Th is product gave measurable fl uorescent signal that was proportional to the number of viable cells. Human keratinocytes and fi broblasts proliferated well on both surfaces (Fig. 6) . Statistical analysis using One-way ANOVA and Tukey post-hoc tests showed no significant diff erence in terms of cell viability between tissue culture plastic and fibrin scaff old (P>0.05).
Immunofl uorescent staining of keratinocyte cultures on fi brin scaff old showed expression of CK19 (marker of epithelial stem cells) and involucrin (marker of diff erentiated keratinocytes) (Fig. 7) . Fibroblast cultures were identifi ed based on vimentin expression (Fig. 8 ) 25 . Clinical results clearly showed that appearance of the skin did not diff er signifi cantly from the areas of transplantated skin using STSG techniques or CEA. Th e epidermis was undistinguishable from normal epidermis.
Discussion
For more than 30 years, CEA have been used in the treatment of heavily burned patients 24, 26, 27 . Although a great step ahead in regenerative medicine was made, clinical results were not consistent and their application was associated with numerous problems. Reports on CEA take greatly vary from 15% to 85%. Better results were achieved in those burns with proper wound bed preparation, which could be further enhanced by the presence of some kinds of dermal elements 27 . One of the major problems associated with the production of CEA is long cultivation time to get confl uent, 'ripe' multilayered epithelial sheets that can be detached from tissue culture vessels. Meanwhile, 
Viability of cultured fibroblasts
Plastic Fibrin wounds must be covered with temporary substitutes. Th e enzyme dispase was used for detachment of a CEA sheet. Unfortunately, dispase treatment may also impair keratinocyte attachment to the wound bed due to the loss of intergin 6ß4 expression and changes in basement protein expression 28, 29 . In confl uent sheets, more keratinocytes are induced to exit highly proliferative state and enter the irreversible process of terminal diff erentiation. In terminal diff erentiation, their colony forming effi ciency is considerably lower 30 . Some of these problems could be minimized by using cultured skin substitutes that contain both epidermal and dermal components cultured on proper scaff old. Bearing this in mind, cultured skin substitutes on fibrin scaff old were cultivated. Cells were cultured until 80% of confl uence and then transplanted to the patient. Th e use of subconfl uent cells enables more fl exible planning of clinical application, and better adaptation to patient's needs. Th ese substitutes are easy to manipulate, fl exible, transparent and adhere well to the wound bed.
Inverted phase contrast and SEM images of fi broblasts and keratinocyte cultures on fi brin gel showed typical cell morphology and even cell distribution along the scaff old surface. Immunofl uorescence analysis pointed out that keratinocyte cultures on fi brin contained mixed population of cells with the portion of stem cell like cells positive to CK19. CK19, a fibrous protein localized on epidermis and hair follicles, and may be used as a marker for skin and hair follicle stem cell involved in the regeneration and restoration of skin and growth. Th is indicated a high proliferative capacity of cell cultures 30 . Presence of diff erentiated keratinocytes was detected with involucrin 2 . Th e results of this study were in corcordance with the study of Pellegrini et al. 17 . When primary cultures of normal cells are cloned, three types of colony grow, called holoclones, meroclones and paraclones. Holoclones are derived from stem cells capable of extensive proliferation and selfrenewal. Early stage transit-amplifying cells form meroclones with limited proliferative capacity and no ability of self-renewal. Paraclones consist of late stage transit-amplifying cells, incapable of further proliferation 24 . Pellegrini et al.
. used the same method of fi brin scaff old preparation as in this study. Th ey showed normal relative percentages of keratinocyte holoclones, meroclones and paraclones during cultivation on fi brin gel. Moreover, they also proved that keratinocytes preserved their clonogenic ability, growth rate and longterm proliferation potential of the graft 17 .
.
We have to emphasize that we detected cultured fi broblasts in fi brin gel based on vimentin expression 7 . Keratinocyte and fi broblast viability on plastic and fibrin scaff old was very similar, without statistically signifi cant diff erences. In clinical application, our results using skin equivalents did not show more frequent local incidence of scar formation as compared to 'classic' techniques of STSG skin grafting (Figs. 9 and 10 ). Th ese data are highly consistent with other studies [16] [17] [18] [19] [20] [21] . Unlike classic CEA, skin substitutes with fi brin gel are easier to apply in periarticular body portions, i.e. on uneven body surfaces surrounding movable joints, owing to the fact that the fi brin component of the skin substitute glues the graft and no additional staples are necessary.
In conclusion, using fi brin-cultured skin substitutes on massive full-thickness burn will result in good healing (Fig. 10 ) over up to 3-year follow up. Fig. 9 . Appearance of transplanted area 30 days after grafting of skin equivalents in patient 2.
Fig. 10. Transplanted areas after healing with cultured epithelial autografts (A) and skin equivalents in patient 1 (C, D).
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